Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hepatitis C: a current perspective

G C Farrell1

  • 1Department of Medicine, University of Sydney, Westmead Hospital, NSW.

Australian Family Physician
|March 1, 1995
PubMed
Summary
This summary is machine-generated.

Family physicians face challenges diagnosing and treating hepatitis C (HCV). Early screening for at-risk individuals and careful consideration of interferon treatment are recommended, alongside monitoring for liver cancer in cirrhotic patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Causes and mechanisms of adipocyte enlargement and adipose expansion.

Obesity reviews : an official journal of the International Association for the Study of Obesity·2017
Same author

Week 4 viral load predicts long-term suppression of hepatitis B virus DNA during antiviral therapy: improving hepatitis B treatment in the real world.

Internal medicine journal·2016
Same author

PPARgamma inhibits hepatocellular carcinoma metastases in vitro and in mice.

British journal of cancer·2012
Same author

Coordinated improvement in glucose tolerance, liver steatosis and obesity-associated inflammation by cannabinoid 1 receptor antagonism in fat Aussie mice.

International journal of obesity (2005)·2011
Same author

Clinical significance of precore and core promoter mutations in genotype D hepatitis B-related chronic liver disease.

Journal of viral hepatitis·2008
Same author

Is past exposure to hepatitis A protective against progressive fibrosis in non-alcoholic fatty liver disease?

Liver international : official journal of the International Association for the Study of the Liver·2008
Same journal

Occupational violence and staff safety in general practice.

Australian family physician·2018
Same journal

You should get that mole checked out: Ethical and legal considerations of the unsolicited clinical opinion.

Australian family physician·2018
Same journal

Understanding the decision to commence a dose administration aid.

Australian family physician·2018
Same journal

Psychological distress and risky sexual behaviours among women aged 16-25 years in Victoria, Australia.

Australian family physician·2018
Same journal

A mixed-methods feasibility study of routinely weighing patients in general practice to aid weight management.

Australian family physician·2018
Same journal

The Australian Mid-West Coastal Marine Wound Infections Study.

Australian family physician·2018
See all related articles

Area of Science:

  • Hepatology
  • Family Medicine
  • Infectious Diseases

Background:

  • Hepatitis C virus (HCV) presents diagnostic and management dilemmas for family physicians.
  • Current diagnostic approaches rely on risk factor assessment and liver function tests due to the absence of a gold standard.
  • Understanding HCV transmission and treatment efficacy is crucial for clinical practice.

Purpose of the Study:

  • To outline key challenges in managing hepatitis C for family physicians.
  • To provide guidance on screening, diagnosis, and treatment decisions for HCV.
  • To highlight considerations for long-term patient management and complication screening.

Main Methods:

  • Review of current literature and clinical guidelines for hepatitis C management.

Related Experiment Videos

  • Discussion of diagnostic dilemmas, including incidental positive anti-HCV tests.
  • Analysis of factors influencing interferon treatment decisions and hepatocellular carcinoma screening.

    • Main Results:

    • Patients with known risk factors (e.g., injecting drug use, blood transfusion) should be screened for anti-HCV.
    • HCV transmission within families and sexually is rare, with high maternal viral load being a key factor in vertical transmission.
    • Interferon treatment decisions necessitate evaluating disease natural history, treatment response rates, and adverse effects.

    Conclusions:

    • Family physicians require clear strategies for identifying and managing hepatitis C patients.
    • Accurate diagnosis, risk-based screening, and informed treatment choices are essential.
    • Screening for hepatocellular carcinoma in patients with cirrhosis is recommended to improve outcomes.